Skip to main content
. 2010 Mar 25;2(4):782–795. doi: 10.3390/v2040782

Table 1.

Prevalence of Symptoms in H1N1pdm Infected and Uninfected Subjects and “Symptomatic” and “Asymptomatic” Subjects in Targeted Surveillance.

Symptom/s H1N 1pdm Positive (%) N=50 H1N1pdm Negative (%) N=564 p-value “Symptomatic” (%) N=251 “Asymptomatic” (%) N=363 p-value
Rhinorrhea 82 31.2 <0.001 75.3 7.7 <0.001
Cough 80 32.8 <0.001 82.1 5.2 <0.001
Fever 78 19.3 <0.001 59 0 <0.001
Sore throat 38 16.8 <0.001 40.2 3.6 <0.001
Headache 34 15.6 0.018 28.3 9.4 <0.001
Diarrhea 8 8.2 0.99 15.5 3 <0.001
Vomiting 8 10.5 0.99 17.1 5.2 <0.001
Nausea 8 10.3 0.99 28.3 9.4 <0.001
Myalgias 6 2 0.58 4.8 0.6 <0.001
Seizure 0 0.2 0.99 0 0.3 0.99
Rash 0 3.4 0.99 4.8 1.9 0.11
Fever and cough (no sore throat) 36 7.4 - 23.9 0 -
Fever and sore throat (no cough) 2 1.2 - 3.2 0 -
ILI** 68 15.4 <0.001 48.2 0 <0.001
No ILI 32 84.6 - 51.8 100 -
“Symptomatic” 90 36.5 <0.001 - - -
“Asymptomatic” 10 63.5 - - - -
*

“Symptomatic” subjects were those who met any two of the following criteria: fever, cough, sore throat, coryza, or myalgia

**

ILI was defined as presence of subjective fever with cough or sore throat.